Institutional investors purchased a net $1.4 million shares of RTIX during the quarter ended June 2017 and now own 66.14% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 35.5 Thousand shares of RTI Surgical Inc